Bio-Techne (TECH) | Stock Overview & Key Data

Bio-Techne Corporation | Mid-cap | Healthcare

$50.52

-1.96%

| Bio-Techne Stock Comparison:

Bio-Techne vs Vertex Bio-Techne vs Regeneron Bio-Techne vs Blueprint Medicines Bio-Techne vs Roivant Sciences Bio-Techne vs Revolution Medicines Bio-Techne vs S&P 500 | Market

Chart Range Statistics Financials Dividends Returns Ownership Calculator FAQ

Bio-Techne Performance Comparison

Loading chart data...

Bio-Techne

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $50.30 High: $51.35

on June 13, 2025

52 Week Range

Low: $46.01 High: $83.62

on April 21, 2025

on July 31, 2024

All-Time High: $135.96 on September 20, 2021

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $7.9B

EPS i 0.83

P/E Ratio (TTM) i 60.87

Forward P/E i 23.07

P/B Ratio i 3.92

PEG Ratio i 23.07

Div. Yield i 0.63%

ROE i 6.53%

Beta i 1.381

Debt to Equity i 20.99

Financial Highlights

Profitability

Gross Margin i 67.86%

Operating Margin i 14.10%

Profit Margin i 10.89%

Returns and Earnings

Return on Assets (TTM) i 5.24%

Return on Equity (TTM) i 6.53%

EBITDA i $321.2M

Net Income (TTM) i $131.6M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i

Dividend Information

Expected Yearly Dividend i $0.32

Estimated Dividend Yield i 0.63%

5 Year Average Dividend Yield i 0.41%

Last 12-Month Dividend Yield i 0.63%

Last 12-Month Dividend i $0.32

% of Earnings Paid as Dividends i 38.55%

Dividend Date i May 30, 2025

Ex-Dividend Date i May 19, 2025

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Bio-Techne TECH	7.92B Mid-cap	3.76%	-2.11%	-15.63%	-33.25%	-29.32%	-33.41%	-38.23%	-21.59%
Vertex VRTX	115.95B Large-cap	1.10%	5.43%	-9.44%	-1.79%	12.25%	-5.26%	73.12%	55.30%
Regeneron REGN	57.14B Large-cap	7.30%	-7.82%	-22.24%	-27.63%	-26.00%	-48.94%	-8.90%	-17.81%
Blueprint Medicines BPMC	8.27B Mid-cap	0.09%	28.73%	42.43%	37.31%	46.74%	21.23%	163.13%	62.39%
Roivant Sciences ROIV	7.70B Mid-cap	0.80%	5.20%	8.64%	-4.39%	-6.29%	5.89%	158.45%	14.11%
Revolution Medicines RVMD	7.56B Mid-cap	-1.22%	1.60%	4.00%	-9.82%	-7.75%	5.10%	125.37%	7.81%

Ownership & Short Interest

Insider Ownership i 1.06%

Institutional Ownership i 105.63%

Shares Short i 8M

Short Ratio i 2.72

Short % of Shares Outstanding i 5.52%

Average 10-Day Volume i 2M

Average 90-Day Volume i 3M

Bio-Techne Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Bio-Techne would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is TECH's 52-week high and low?

In the last 52 weeks, Bio-Techne reached a high of $83.62 (on July 31, 2024) and a low of $46.01 (on April 21, 2025).

What is the market cap and P/E ratio for TECH?

Curious about Bio-Techne's size and valuation? Its market capitalization stands at 7.92B. When it comes to valuation, the P/E ratio (trailing twelve months) is 60.87, and the forward P/E (looking ahead) is 23.07.

Does TECH pay dividends? If so, what's the yield?

Yes, Bio-Techne is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.63%, and the company is expected to pay out $0.32 per share over the coming year.

Who are Bio-Techne's main competitors or similar companies to consider before investing?

When looking at Bio-Techne, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	115.95B	Healthcare	Biotechnology	-5.26%	73.12%
Regeneron REGN	57.14B	Healthcare	Biotechnology	-48.94%	-8.90%
Blueprint Medicines BPMC	8.27B	Healthcare	Biotechnology	21.23%	163.13%
Roivant Sciences ROIV	7.70B	Healthcare	Biotechnology	5.89%	158.45%
Revolution Medicines RVMD	7.56B	Healthcare	Biotechnology	5.10%	125.37%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Bio-Techne Corporation? (e.g., ROE, Debt/Equity)

To get a sense of Bio-Techne's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 6.53%, the Debt to Equity ratio from the most recent quarter is 20.99, and its Gross Profit Margin stands at 67.86%.

What is the recent revenue and earnings growth for TECH?

Looking at Bio-Techne's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 4.20%, and quarterly earnings saw a YoY growth of -54.00%.

How much of TECH stock is held by insiders and institutions?

Wondering who owns Bio-Techne stock? Company insiders (like executives and directors) hold about 1.06% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 105.63%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.